Brief: Geneuro’S Temelimab Phase IIa Data Confirms Rainbow Positive Results

Geneuro SA

07/05/2019 06:32

May 7 (Reuters) - GENEURO SA  GNRO.PA :
    * GENEURO’S TEMELIMAB PHASE IIA DATA IN TYPE 1 DIABETES AT
12
MONTHS CONFIRMS RAINBOW POSITIVE RESULTS
    * STUDY MEETS OBJECTIVE OF DEMONSTRATING SAFETY AND
PHARMACODYNAMIC RESPONSE
    * CONFIRMED EXCELLENT SAFETY PROFILE IN COMBINATION WITH
CONCOMITANT MEDICATIONS, WITH NO SERIOUS ADVERSE EVENTS
    * OPENS WAY FOR FURTHER DEVELOPMENT IN EARLY-ONSET PEDIATRIC
POPULATION

Source text for Eikon:  ID:nBw1pZCt9a 
Further company coverage:  GNRO.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))